Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
| ▸ | EED | O75530 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4281534 | 0.91 | CCR3 (0.49) | CCR3EEDCA1CA2CA4 | |
| SCHEMBL19002806 | 0.89 | CCR3 (0.47) | CCR3EEDCA1CA2CA4 | |
| SCHEMBL21169224 | 0.88 | CCR3 (0.47) | CCR3EEDCA1CA2CA4 | |
| SCHEMBL13705102 | 0.86 | CCR3 (0.45) | CCR3EEDCA1CA2CA4 | |
| SCHEMBL6132670 | 0.86 | CCR3 (0.45) | CCR3EEDCA1CA2CA4 | |
| SCHEMBL19049071 | 0.83 | CA1 (0.46) | CCR3CA1CA2CA4CA9 | |
| SCHEMBL19049072 | 0.82 | CA1 (0.60) | CA1CA2CA4CA9ABCB1 | |
| Hydrochloric Acid SCHEMBL6133157 | 0.81 | RHOA (0.52) | CCR3OPRK1CA1CA2CA4 | |
| SCHEMBL23222258 | 0.80 | SLC6A4 (0.45) | EEDHTR1ASLC6A4SIGMAR1KDM4E | |
| SCHEMBL13858982 | 0.79 | SLC6A4 (0.47) | EEDHTR1ASLC6A4SIGMAR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3642209-B1 | COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE | SHY Therapeutics LLC (US) | 2023-11-29 | — | — | EP | disclosed |
| EP-3394056-B1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC (US) | 2021-04-14 | — | — | EP | disclosed |
| WO-2017112777-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC (US) | 2017-06-29 | — | — | WO | disclosed |